We are excited to announce the launch of the first edition of the Strategy Program, a premier global initiative designed to enhance leadership expertise with a strategic approach. This 9-month program is set to shape the future of our organization by preparing individuals for key senior leadership roles. In collaboration with Esade Business School, participants will engage in a rigorous curriculum that combines theoretical knowledge with practical application to build high-performing, inclusive teams, ensuring they are well-equipped to lead our organization into the future. This program underscores Grifols' commitment to nurturing talent and driving excellence at every level. #WeAreGrifols #LeadingTheFuture #businessstrategy
Grifols
Fabricación de productos farmacéuticos
Sant Cugat del Vallès, Barcelona 239.175 seguidores
Innovamos para los pacientes y la Sociedad
Sobre nosotros
Grifols es una compañía global del sector de la salud fundada en 1909, comprometida con mejorar la salud y el bienestar de las personas en todo el mundo. Somos líderes en medicamentos hemoderivados y medicina transfusional y desarrollamos, producimos y proporcionamos servicios y soluciones sanitarias innovadoras en más de 110 países. Las necesidades de los pacientes y nuestro creciente conocimiento de muchas enfermedades crónicas, raras y prevalentes, a veces muy graves, impulsan nuestra innovación para desarrollar medicamentos derivados del plasma y otros productos biofarmacéuticos que mejoren la calidad de vida de las personas. Los tratamientos que ofrece Grifols son para patologías de una amplia gama de áreas terapéuticas: inmunología, hepatología, cuidados intensivos, neumología, hematología, neurología y enfermedades infecciosas. Grifols, con una plantilla de más de 27.000 personas en más de 30 países y regiones, apuesta por un modelo de negocio sostenible, referente de innovación continua, calidad, seguridad y liderazgo ético. Nuestro trabajo diario genera impacto social y económico positivo en las comunidades en las que estamos presentes, a través de la creación de puestos de trabajo y valor social. Las personas están en el centro de todo lo que hacemos y nos esforzamos por crear una sociedad inclusiva, diversa, justa e igualitaria. Mantener y promover una plantilla que refleje esta realidad conduce a mejorar las relaciones profesionales y nos ayuda a dar lo mejor de nosotros mismos a pacientes, donantes y clientes. En 2022, Forbes reconoció a Grifols como una de las mejores compañías para mujeres trabajadoras (Best Employers for Women), una de las mejores empresas grandes en las que trabajar en EE.UU (America’s Best Large Employers) y una de las 75 mejores empresas para trabajar en España.
- Sitio web
-
https://linktr.ee/Grifols
Enlace externo para Grifols
- Sector
- Fabricación de productos farmacéuticos
- Tamaño de la empresa
- Más de 10.001 empleados
- Sede
- Sant Cugat del Vallès, Barcelona
- Tipo
- Empresa pública
- Fundación
- 1909
- Especialidades
- Plasmapheresis, Plasma derived therapies, Diagnostics, Intravenous therapies, Clinical nutrition, Automate drug compounding , Drug inventory control y Healthcare
Ubicaciones
-
Principal
Parc Empresarial Can Sant Joan
Av. de la Generalitat, 152-158
Sant Cugat del Vallès, Barcelona 08174, ES
-
Carrer de Palou, 6
Parets del Valles, Catalonia 08150, ES
Empleados en Grifols
Actualizaciones
-
We are pleased to announce that GigaGen, a subsidiary of Grifols, has been awarded a contract by the Biomedical Advanced Research and Development Authority (BARDA) within the U.S. Department of Health and Human Services (HHS) to develop a recombinant polyclonal antibody therapy for botulinum neurotoxins (BoNTs) and a second biothreat of interest to the agency. The contract, worth up to $135.2M, will support the creation, manufacturing and initial clinical development of a drug product that targets the biothreats of both programs. For more information, see the press release 👉 http://spr.ly/6042Uruj8 #WeAreInnovation #biothreats
-
This year marks an incredible milestone for Grifols UK, as we celebrate 45 years of business in the UK. Starting in Thetford in October, 1979 as Alpha Therapeutic UK Ltd, and becoming Grifols UK Ltd in 1998, we have grown to become a trusted supplier of essential healthcare products and services. Today, with nearly 70 employees across our Biopharma and Diagnostics divisions, we’re proud to continue providing those products and services that improve patients' health and quality of life across Great Britain and Northern Ireland. We want to thank the talented individuals who have contributed to our success, as well as our strong partnerships with the UK healthcare system. 🎉 Here’s to many more years of success, innovation, and making a difference! #GrifolsUK #WeAreHealthcare
-
Our site in Dublin (Ireland) has become a key international center for manufacturing, logistics and global supply for our Biopharma business unit. Three years ago, we initiated a global transformation to optimize and improve supply chain operations to ensure a more efficient and collaborative process throughout the organization. We want you to meet Colum Meehan, he’s leading from Ireland the transformation of our End-to-End Supply Chain. His goal is to improve the agility of the company, to optimize the supply chain to easily adapt to market changes. #SupplyChain #GrifolsIreland #GrifolsTeam
-
During Global ITP Awareness Week, we join with the international community and ITP patient organizations around the world to promote public awareness of this rare autoimmune disease. Affecting 10-62 people per 100,000 worldwide, Immune thrombocytopenia (ITP) is a blood disorder in which the immune system attacks and destroys the body's own blood platelets, which are essential for clotting blood. At Grifols we foster research and innovation in awareness, diagnosis and management of ITP through our GRAIT Awards Program to benefit patients everywhere. To learn more, visit 👉 https://ow.ly/wTyC50POv2k #autoimmunedisease #itpawareness #blooddisorder #WhatWeDoMatters
-
When was the last time you challenged yourself? Pedro, Adela, Luis and Montse do it every day. They live with physical disabilities or reduced mobility. They are users of the Fundació Isidre Esteve and shared a training session in couples with some Grifols employees to show them the challenges they face every day. Grifols Social Initiatives is supporting the foundation's initiative, Centre Pont, that provides rehabilitation services for individuals facing vulnerable situations. Our collaboration is driven by a shared commitment to disability inclusion. At Grifols, this commitment is integral to our corporate ethos, driving innovation, fostering collaboration, and creating a workplace where every individual can thrive. Today's activity is part of our diversity and inclusion strategy, to eliminate prejudice and contribute to the integration of people with disabilities in the workplace. ▶️ Don’t miss the video on Instagram 👉 http://spr.ly/6040obtdQ #DiversityandInclusion #WeAreGrifols #GrisolsSocialInitiatives
-
On World Cleanup Day, we are proud to share the inspiring actions taken by our teams worldwide. A group of 48 dedicated employees from our Beijing and Shanghai offices joined forces with Pick Up China for a mountain clean-up in Anji. Their collective effort resulted in the removal of 40 kilograms of waste and nearly 900 recyclable items from beautiful mountain trails. Throughout the year, employees from 10 of our plasma centers and from our sites in San Diego and Clayton, in the U.S, have also participated in initiatives in Community Clean-ups to raise awareness of the impact of littering and the importance of responsible environmental protection. These initiatives are part of a larger global movement that not only aims to clean our planet but also to shift attitudes towards waste and its impact on land, rivers, and oceans. We're honored to participate in this campaign, especially as World Cleanup Day is now recognized by the United Nations as an International Day. #WorldCleanupDay #Sustainability #WhatWeDoMatters
-
We believe in empowering our people to become the leaders of tomorrow, and the GROW Program is a key part of that mission. 🚀 Over the course of 8 months, this global initiative provides high-potential employees with transformative experiences through group coaching, in-person and virtual development sessions, and invaluable mentor connections. We recently hosted our second in-person development sessions in Los Angeles and Barcelona . Key topics included self-leadership and building strong connections to overcome challenges. The LA session featured a Leadership panel, while the Barcelona session introduced an innovation workshop to tackle a real business learning challenge. At Grifols, developing our people is a cornerstone of our strategic vision. #LeadershipDevelopment #PeopleFirst #FutureLeaders #WeAreGrifols
-
We are proud to announce that the winner of the 2024 ALBUS Awards is Bryce A. Kerlin, MD, Professor of Pediatrics at The Ohio State University College of Medicine, and principal investigator at The Abigail Wexner Research Institute at Nationwide Children's Hospital. Dr. Kerlin is being recognized for his research project “Albumin-Dependent Endothelial Cytoprotection”, aiming to identify the specific molecular receptor responsible for albumin-dependent endothelial cytoprotection, with the goal of enabling the development of receptor agonists to stabilize the endothelium and improve cardiovascular outcomes in conditions associated with hypoalbuminemia. Founded in 2015 the ALBUS Program is an annual international award focused on innovative ideas related to albumin and its role as a therapeutic product. At Grifols, we are committed to pushing the boundaries of scientific knowledge to improve people’s health. Applications for the next Albus Award edition open on November 1st. For more information 👉 http://spr.ly/6045oDQev #hematology #GrifolsScientificAwards
-
On World Patient Safety Day, we join forces with patients, families, healthcare professionals and policy makers under the banner "Get it right, make it safe!" to emphasize the critical importance of accurate and timely diagnosis for patient safety. Grifols' legacy of innovation, from pioneering plasmapheresis to advancing diagnostic technologies, underscores our mission to ensure a safer tomorrow for patients worldwide. We believe that every patient deserves the highest standards of safety, quality, and reliability in their healthcare journey. #WorldPatientSafetyDay #PatientSafety #EarlyDiagnosis
Páginas asociadas
-
Grifols Biopharma
Fabricación de productos farmacéuticos
08174 Sant Cugat del Vallès, Barcelona
-
Grifols Diagnostic
Fabricación de equipo médico
Sant Cugat del Vallès, Barcelona
-
Grifols Healthcare Solutions
Hospitales y atención sanitaria
Sant Cugat del Vallès, Barcelona
-
Grifols Bio Supplies
Investigación biotecnológica
Páginas similares
Buscar empleos
Financiación
Última ronda
Deuda tras OPV326.451.020,00 US$